Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy
Source : https://pubmed.ncbi.nlm.nih.gov/37844687/
Chronic GVHD appeared closely associated with both SN and NM-LE in adult survivors of HCT for hematologic malignancy. Patients identified as having more severe involvement and both mucocutaneous and visceral...
Chronic GVHD appeared closely associated with both SN and NM-LE in adult survivors of HCT for hematologic malignancy. Patients identified as having more severe involvement and both mucocutaneous and visceral organ involvement may warrant enhanced monitoring and screening for SNs and NM-LEs.
Incidence and Risk Factors of Graft-Versus-Host Disease After Liver Transplantation: a National Study 2010–2020
haring. This is the first national analysis of the incidence and risk factors of GVHD after LT. Methods: This retrospective cohort study used the National Readmission Database to calculate the...
Our study found that the incidence rate of GVHD within 1 year of LT in the United States was 1.0% and remained stable from 2010 to 2020. The predictors associated with GVHD include alcohol-associated liver disease and COVID-19.
Therapeutic Response of Oral Chronic Graft-Versus-Host Disease to Topical Corticosteroids According to the 2014 National Institutes of Health (USA) Consensus Criteria
Source : https://pubmed.ncbi.nlm.nih.gov/37823294/
The oral cGVHD lesions and functional impacts improved within 6 months and 9 months, respectively. However, most of the patients required topical corticosteroid therapy for more than 1 year to...
The oral cGVHD lesions and functional impacts improved within 6 months and 9 months, respectively. However, most of the patients required topical corticosteroid therapy for more than 1 year to control their symptoms and lesions.
Risk Factors and Clinical Characteristics of Acute and Chronic Cutaneous Graft-Versus-Host Disease in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
Source : https://pubmed.ncbi.nlm.nih.gov/37830789/
Acute and chronic cutaneous graft-versus-host disease (GVHD) are common complications following hematopoietic stem cell transplantation (HSCT) in pediatric patients. In this retrospective study, we explored the risk factors and clinical...
Our study highlights the importance of identifying and monitoring these high-risk patients to improve the clinical management and outcomes of cutaneous GVHD in pediatric HSCT recipients.
Adolescent and Young Adult Patients with Vaginal Graft-Versus-Host Disease and Hematocolpos Managed With Vaginal Stents: a Case Series
Source : https://pubmed.ncbi.nlm.nih.gov/37797789/
Vaginal stenosis secondary to vaginal GVHD should be considered in patients with a history of allogeneic HSCT presenting with amenorrhea, especially those with a diagnosis of primary ovarian insufficiency. The...
Vaginal stenosis secondary to vaginal GVHD should be considered in patients with a history of allogeneic HSCT presenting with amenorrhea, especially those with a diagnosis of primary ovarian insufficiency. The use of vaginal stents, along with postoperative medical and dilator management as appropriate, may prevent re-stenosis, although more...